Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000050.xml
Download PDF
Seminars in Neurosurgery 2001; 12(2): 161-168
DOI: 10.1055/s-2001-17122
DOI: 10.1055/s-2001-17122
Guidelines for Patient Selection for Ablative and Deep Brain Stimulation Surgery
Further Information
Publication History
Publication Date:
13 September 2001 (online)
ABSTRACT
A series of complementary technological and scientific advances have revived interest in the surgical management of movement disorders. Deep brain stimulation (DBS) is the most important of these advances because it has expanded the indications for surgical intervention, made treatment at new targets possible, and improved the functional impact of surgery. Consequently, the selection of surgical candidates is more complex and more important to the successful management of movement disorder patients than ever before. In this article we discuss our protocol for evaluating surgical candidates, stressing the importance of the multidisciplinary team approach and strict selection criteria. Critical factors include detailed clinical assessment, neurocognitive testing, and when appropriate, positron emission tomography (PET). Indications for specific interventions, both approved and ``investigational,'' are also discussed. Although stereotactic surgery for movement disorders is becoming safer and more effective, adverse neurologic sequelae can still occur. Therefore, surgery still should only be considered for patients who are functionally disabled by symptoms that are refractory to medical treatment.
KEYWORD
Stereotactic surgery - deep brain stimulation - positron emission tomography - Parkinson's disease - tremor
REFERENCES
- 1 Marsden C D, Parkes J D. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet . 1977; 1 345-349
- 2 Chase T N, Fabbrini G, Juncos J L, Mouradian M M. Motor response complications with chronic levodopa therapy. Adv Neurol . 1990; 53 377-381
- 3 Poewe W. Adjuncts to levodopa therapy: dopamine agonists. Neurology . 1998 (suppl 6); 50 (S23-26)
- 4 Factor S A. Dopamine agonists. In: Stern MB, Hurtig HH, eds. Parkinson's Disease and Parkinsonian Syndromes Med Clin North Am 1999 83(2): 415-443
MissingFormLabel
- 5 King J, Tsui C. Treatment of Parkinson's disease. In: Calne DB, ed. Neurodegenerative Diseases
Philadelphia: WB Saunders Co 1994: 573-582
MissingFormLabel
- 6 Obeso J A, Rodriguez-Oroz M C, Rodriguez M. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci . 2000; 23(10 suppl) S8-19
- 7 Wichmann T, DeLong M R. Models of basal ganglia function and pathophysiology of movement disorders. Neurol Clin North Am . 1998; 9 223-236
- 8 Tasker R R, Lenz F, Yamashiro K, Gorecki J, Hirayama T, Dostrovsky J O. Microelectrode techniques in localization of stereotactic targets. Neurol Res . 1987; 9 105-112
- 9 Benabid A L, Koudsie A, Pollak P. Future prospects of brain stimulation. Neurol Res . 2000; 22 237-246
- 10 Gross R E, Lozano A M. Advances in neuromodulation for movement disorders. Neurol Res . 2000; 22 247-258
- 11 Alterman R L, Kelly P, Sterio D. Selection criteria for unilateral posteroventral pallidotomy. Acta Neurochir . 1997; 68(suppl) 18-23
- 12 Fahn S, Elton R L, Members of the UPDRS development committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's
disease
Vol 2. Florham Park, NJ: MacMillan Healthcare Information 1987: 153-164
MissingFormLabel
- 13 Folstein M, Folstein S, McHugh P J. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psych Res . 1975; 12 189-198
- 14 Limousin P, Krack P, Pollak P. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl J Med . 1998; 339 1105-1111
- 15 Saint-Cyr J A, Trepanier L L, Kumar R, Lozano A M, Lang A E. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain . 2000; 123 2091-2108
- 16 Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders.
2nd ed. Philadelphia, PA: Lea & Febiger; 1983
MissingFormLabel
- 17 Wechsler D. WISC-III Manual.
San Antonio,TX: The Psychological Corp, Harcourt Brace; 1991
MissingFormLabel
- 18 Smith A. The symbol digit modalities test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learning Disord . 1968; 3 83-91
- 19 Hooper H E. Hooper visual organization test (VOT).
Los Angeles, CA: Western Psychological Services; 1983
MissingFormLabel
- 20 Rey A. L'examen clinique en psychologie.
Paris: Presses Universitaires de France; 1966
MissingFormLabel
- 21 Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychologie . 1941; 28 286-340
- 22 Benton A L, Hamsher K D. Multilingual Aphasia Examination.
Iowa City, IA: AJA Associates; 1989
MissingFormLabel
- 23 Reitan R M, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Interpretation.
Tucson, AZ: Neuropsychology Press; 1985
MissingFormLabel
- 24 Heaton R K. Wisconsin Card Sorting Test: Manual.
Odessa, FL: Psychological Assessment Resources; 1981
MissingFormLabel
- 25 Golden C J. Stroop Color and Word Test.
Chicago, IL: Stoelting; 1978
MissingFormLabel
- 26 Klove H. Clinical neuropsychology. In: Forster FM, ed. The Medical Clinics of North America
New York, NY: WB Saunders 1963: 1647-1658
MissingFormLabel
- 27 Rajput A H, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci . 1991; 18 275-278
- 28 Dogali M, Fazzini E, Kolodny E. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology . 1995; 45 753-761
- 29 Jankovic J, Rajput A H, McDermott M P, Perl D P. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol . 2000; 57 369-372
- 30 Litvan I, Booth V, Wenning G K. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm . 1998; 105 217-227
- 31 Litvan I, Agid Y, Calne D. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology . 1996; 47 1-9
- 32 Antonini A, Kazumata K, Feigin A. Differential diagnosis of parkinsonism with [18F] fluorodeoxyglucose and PET. Mov Disord . 1998; 13 268-74
- 33 Kazumata K, Antonini A, Dhawan V. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology . 1997; 49 1083-1090
- 34 Tasker R R. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol . 1998; 49 145-154
- 35 Schuurman P R, Bosch D A, Bossuyt P M. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. New Engl J Med . 2000; 342 461-468
- 36 Benabid A L, Pollak P, Gervason C. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet . 1991; 337 403-446
- 37 Benabid A L, Pollak P, Gao D. Chronic electrical stimulation of the VIM nucleus of the thalamus as a treatment of movement disorders. J Neurosurg . 1996; 84 203-214
- 38 Koller W C, Pahwa R, Busenbark K. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol . 1997; 42 292-299
- 39 Hubble J P, Busenbark K L, Wilkinson S. Deep brain stimulation for essential tremor. Neurology . 1996; 46 1150-1153
- 40 Koller W C, Pahwa R, Lyons K E, Albanese A. Surgical treatment of Parkinson's disease. J Neurol Sci . 1999; 167 1-10
- 41 Taha J M, Janszen M A, Favre J. Thalamic deep brain stimulation for the treatment of head, voice and bilateral limb tremor. J Neurosurg . 1999; 91 68-72
- 42 Schulder M, Sernas T, Mahalick D. Thalamic stimulation in patients with multiple sclerosis. Stereotact Funct Neurosurg . 1999; 72 196-201
- 43 Montgomery E B, Baker K B, Kinkel R P, Barnett G. Chronic thalamic stimulation for the tremor of multiple sclerosis. Neurology . 1999; 53 625-628
- 44 Thompson T P, Kondziolka D, Albright A L. Thalamic stimulation for choreiform movement disorders in children. Report of two cases. J Neurosurg . 2000; 92 718-721
- 45 Laitinen L V, Bergenheim A T, Hariz M I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg . 1992; 76 53-61
- 46 Lang A E, Duff J, Saint-Cyr J A. Posteroventral medial pallidotomy in Parkinson's disease. J Neurol . 1999 (suppl 2); 246 (II28-41)
- 47 Lang A E. Surgery for levodopa-induced dyskinesias. Ann Neurol . 2000 (suppl 1); 47 (S193-199)
- 47a Limousin P, Pollak P, Bennazzouz A. Bilateral subthalmic nucleus stimulation for severe Parkinson's disease. Mov Disord . 1995; 10(5) 672-674
- 48 Tronnier V M, Fogel W. Pallidal stimulation for generalized dystonia. Report of three cases. J Neurosurg . 2000; 92 453-456
- 49 Cooper I S. 20-year follow-up study of the neurosurgical treatment of Dystonia Musculorum Deformans. Adv Neurol . 1976; 14 423-452
- 50 Ondo W G, Desaloms J M, Jankovic J, Grossman R G. Pallidotomy for generalized dystonia. Mov Disord . 1998; 13 693-698
- 51 Vayssiere N, Hemm S, Zanca M. Magnetic resonance imaging stereotactic target localization for deep brain stimulation in dystonic children. J Neurosurg . 2000; 93 784-790
- 52 Bergman H, Wichmann T, DeLong M R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science . 1990; 249 1436-1438
- 53 Benabid A, Koudsie A, Benazzouz A. Subthalamic stimulation for Parkinson's disease. Arch Med Res . 2000; 31 282-289